Bioceltix Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	542	388	397	372	133	172
Market Cap Growth	3.86%	-2.39%	6.93%	179.48%	-22.49%	-
Enterprise Value	481.6	319.59	363.94	362.42	129.04	165.67
Last Close Price	98.00	77.60	87.60	90.00	38.80	52.20
PB Ratio	8.02	5.29	10.34	35.51	25.82	28.60
P/TBV Ratio	7.47	5.29	10.35	35.62	29.52	27.52
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.03	0.02
Net Debt / Equity Ratio	-0.90	-0.93	-0.87	-0.88	-0.76	-0.98
Net Debt / EBITDA Ratio	14.72	10.91	2.32	0.68	0.47	1.49
Net Debt / FCF Ratio	4.25	34.67	1.88	0.61	0.48	1.47
Quick Ratio	26.72	39.30	13.26	5.92	2.78	7.28
Current Ratio	26.88	39.39	13.55	5.94	2.79	7.29
Return on Equity (ROE)	-5.99%	-10.83%	-60.95%	-175.28%	-160.01%	-94.35%
Return on Assets (ROA)	-6.03%	-10.66%	-55.20%	-137.43%	-111.74%	-67.39%
Return on Invested Capital (ROIC)	-74.53%	-126.56%	-488.52%	-1147.39%	-1358.49%	-3498.25%
Return on Capital Employed (ROCE)	-6.27%	-11.11%	-60.39%	-165.52%	-132.92%	-75.16%
Buyback Yield / Dilution	-8.77%	-10.18%	-9.51%	-5.70%	-23.93%	-27.81%
Total Shareholder Return	-8.77%	-10.18%	-9.51%	-5.70%	-23.93%	-27.81%